ArticleLeukemia2026
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.
Carmelo Gurnari et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it